By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CSL Biotherapies 

P.O. Box 60446
1020 First Avenue
King of Prussia  Pennsylvania  19406  U.S.A.
Phone: 888-4FLU-OFF Fax: n/a




Company News
CSL Biotherapies Renamed bioCSL Inc. 2/27/2014 9:53:54 AM
CSL Biotherapies Completes 2013-14 Season AFLURIA® Shipments 9/24/2013 8:55:21 AM
CSL Biotherapies Initiates Shipments of Its Seasonal Influenza Vaccine to U.S. Customers 8/7/2013 8:32:22 AM
CSL Biotherapies Awarded US Government Contract for Influenza Pandemic Preparedness and Response 9/12/2012 10:33:47 AM
CSL Biotherapies Receives US FDA Warning for GMP Violations at Vaccine Plant 6/28/2011 8:39:34 AM
CSL Biotherapies Obtains FDA Licensure for Use of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine in Children 11/12/2009 9:10:48 AM
Merck & Co., Inc. (MRK) (JOBS) Obtains Exclusive U.S. Marketing Rights for AFLURIA(R), Seasonal Influenza Vaccine from CSL Biotherapies 9/28/2009 6:20:59 AM
CSL Biotherapies Announces Start of U.S. H1N1 Vaccine Clinical Trials 8/24/2009 9:21:18 AM
CSL Biotherapies Starts Shipment of Seasonal Influenza Vaccine for the 2009-2010 Flu Season 7/27/2009 8:29:34 AM
CSL Biotherapies Contracts with U.S. Department of Health and Human Services to Provide Novel A (H1N1) Influenza Vaccine Antigen 5/29/2009 8:40:50 AM